ropivacainhydrochlorid sintetica (ropivacaine sintetica 2 mg/ml stungulyf, lausn) innrennslislyf, lausn 2 mg/ml
sintetica gmbh - ropivacainum hýdróklóríð - innrennslislyf, lausn - 2 mg/ml
ropivacainhydrochlorid sintetica (ropivacaine sintetica 2 mg/ml stungulyf, lausn) stungulyf, lausn 2 mg/ml
sintetica gmbh - ropivacainum hýdróklóríð - stungulyf, lausn - 2 mg/ml
baclofen sintetica í mænuvökva innrennslislyf, lausn 2 mg/ml
sintetica gmbh - baclofenum inn - innrennslislyf, lausn - 2 mg/ml
ropivacainhydrochlorid sintetica stungulyf, lausn 7,5 mg/ml
sintetica gmbh - ropivacainum hýdróklóríð - stungulyf, lausn - 7,5 mg/ml
ephedrine sintetica stungulyf, lausn 50 mg/ml
sintetica gmbh - ephedrinum hýdróklóríð - stungulyf, lausn - 50 mg/ml
biorphen stungulyf, lausn 10 mg/ml
sintetica gmbh - phenylephrinum hýdróklóríð - stungulyf, lausn - 10 mg/ml
biorphen stungulyf/innrennslislyf, lausn 0,1 mg/ml
sintetica gmbh - phenylephrinum hýdróklóríð - stungulyf/innrennslislyf, lausn - 0,1 mg/ml
improvac
zoetis belgium sa - synthetic peptide analogue of gnrf conjugated to diptheria toxoid - Ónæmissjúkdómar fyrir suidae - male pigs (from 8 weeks of age); female pigs (from 14 weeks of age) - male pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of testicular function. for use as an alternative to physical castration for the reduction of boar taint caused by the key boar taint compound androstenone, in entire male pigs following the onset of puberty. einnig er hægt að minnka annan lykilframlag í söguna, skatole, sem óbein áhrif. Árásargjarn og kynferðisleg (uppbyggjandi) hegðun er einnig minni. female pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of ovarian function (suppression of oestrus) in order to reduce the incidence of unwanted pregnancies in gilts intended for slaughter, and to reduce the associated sexual behaviour (standing oestrus).
anidulafungin normon stofn fyrir innrennslisþykkni, lausn 100 mg
laboratorios normon s.a. - anidulafunginum inn - stofn fyrir innrennslisþykkni, lausn - 100 mg
ecalta
pfizer europe ma eeig - anidulafungin - candidiasis - sveppalyf fyrir almenn nota - meðferð innrásar sveppasýkingu í fullorðna og börn sjúklinga á aldrinum 1 mánuð til að < 18 ára.